Skip to main content
OpenTrials
Completed

NCT Number: NCT01067482

The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes

The purpose of this study is to evaluate performances of each parameters of spectral domain (Cirrus) optical coherence tomography for distinguishing between normal eyes, glaucoma suspect and glaucomatous eyes

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University

Hat Yai, Songkhla, Thailand., 90110, Thailand

About this study

Aim to determine which parameter of cirrus OCT is best sensitivity and specificity for glaucoma detection

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BCVA at least 20/60
  • refractive error +/- 5 D Or astig +/- 3 D
  • enrolled in 3 population group (glaucoma, glaucoma suspect or normal)

Exclusion criteria

  • VA less than 20/60
  • marked RF error
  • previous ocular trauma or surgery
  • unreliable visual field
  • poor signal cirrus OCT (less than 7)
  • other causes of optic nerve or macular disease other than glaucoma

Sponsors and collaborators

Lead sponsor

Prince of Songkla University

Other

Registry information

Official study title

The Performances of Spectral Domain Optical Coherence Tomography for Distinguishing Between Normal Eyes, Glaucoma Suspect and Glaucomatous Eyes

Acronym: cirrusOCT

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Feb 11, 2010
Registry last updated
Mar 23, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.